| Completed | The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Health Healthy Subjects | Phase 1 | 2025-06-24 |
| Completed | Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers Healthy Adult Male Volunteers | Phase 1 | 2024-08-09 |
| Completed | An Exploratory Study of MT-2990 in Patients With AAV Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV) | Phase 1 | 2024-06-24 |
| Active Not Recruiting | A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | 2023-01-30 |
| Completed | Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects ALS | Phase 3 | 2022-10-26 |
| Completed | A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males Healthy Adult Males | Phase 1 | 2022-08-03 |
| Active Not Recruiting | A Study of MT-0551 in Patients With Systemic Sclerosis Systemic Sclerosis | Phase 3 | 2022-07-20 |
| Completed | A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM) HTLV-1-Associated Myelopathy (HAM) | Phase 1 | 2022-05-02 |
| Completed | Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy Painful Diabetic Peripheral Neuropathy | Phase 2 | 2021-11-16 |
| Completed | Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube Healthy Adult Subjects | Phase 1 | 2021-02-26 |
| Completed | Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy Japanese Patients With ALS | Phase 1 | 2020-01-24 |
| Completed | Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study) Healthy Adult Subjects | Phase 1 | 2019-06-10 |
| Completed | Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis Japanese Patients With ALS | Phase 1 | 2019-04-17 |
| Completed | Confirmatory Study of BK1310 in Healthy Infants Tetanus, Diphtheria, Pertussis | Phase 3 | 2019-04-01 |
| Completed | Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects Healthy Adult Subjects | Phase 1 | 2019-03-22 |
| Completed | PK Study in Subjects With Severe Hepatic Impairment Severe Hepatic Impairment, Healthy | Phase 1 | 2018-11-06 |
| Completed | Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary R Healthy Adult Subjects | Phase 1 | 2018-10-17 |
| Completed | A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Co Healthy Adult Subjects | Phase 1 | 2018-09-18 |
| Completed | Effects of Iron Supplements on the Pharmacokinetics of MT-6548 Healthy | Phase 3 | 2018-08-27 |
| Completed | A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients Seasonal Allergic Rhinitis | Phase 1 | 2018-07-17 |
| Completed | Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants Healthy | Phase 1 | 2018-07-03 |
| Completed | Study of Oral Edaravone in Healthy Adult Males Healthy Adult Subjects | Phase 1 | 2018-03-20 |
| Completed | Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associat Anemia; Hemodialysis Dependent Chronic Kidney Disease | Phase 3 | 2018-03-05 |
| Completed | Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy Diabetic Nephropathy | Phase 3 | 2018-02-15 |
| Completed | Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia As Anemia; Hemodialysis Dependent Chronic Kidney Disease | Phase 3 | 2018-02-14 |
| Completed | Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chro Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease | Phase 3 | 2018-01-03 |
| Terminated | Dose Finding Study of MCI-186 in Acute Ischemic Stroke Acute Ischemic Stroke | Phase 2 | 2017-11-17 |
| Completed | Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kid Anemia; Non-dialysis Dependent Chronic Kidney Disease | Phase 3 | 2017-10-30 |
| Completed | Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain Osteoarthritis, Knee / Osteoarthritis, Hip | Phase 2 / Phase 3 | 2017-09-08 |
| Completed | Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Painful Diabetic Peripheral Neuropathy | Phase 2 | 2017-07-25 |
| Completed | Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants Immunization | Phase 3 | 2017-06-23 |
| Completed | Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia Tardive Dyskinesia | Phase 2 / Phase 3 | 2017-06-21 |
| Completed | A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up b Healthy | Phase 1 | 2017-05-17 |
| Completed | Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment Hepatic Impairment, Healthy | Phase 1 | 2016-11-16 |
| Completed | A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers Healthy | Phase 1 | 2016-11-01 |
| Completed | Phase 3 Study of BK1310 in Healthy Infants Immunization; Infection | Phase 3 | 2016-11-01 |
| Completed | Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment Renal Impairment, Healthy | Phase 1 | 2016-10-27 |
| Completed | Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 3 | 2016-09-01 |
| Completed | Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Me Type 2 Diabetes Mellitus | Phase 3 | 2016-09-01 |
| Completed | Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) NASH | Phase 2 | 2016-09-01 |
| Completed | Mass Balance Study of MT-3995 Healthy | Phase 1 | 2016-08-01 |
| Completed | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects Healthy | Phase 1 | 2016-07-01 |
| Completed | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Su Vasomotor Symptoms | Phase 1 | 2016-06-01 |
| Completed | A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Health Healthy | Phase 1 | 2016-02-01 |
| Completed | An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy Diabetic Nephropathy | Phase 2 | 2016-02-01 |
| Completed | A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects Healthy | Phase 1 | 2015-08-01 |
| Completed | Extension Study of MT-1303 in Subjects With Crohn's Disease Crohn's Disease | Phase 2 | 2015-08-01 |
| Completed | Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy Diabetic Nephropathy | Phase 2 | 2015-07-01 |
| Completed | Drug Interaction Study of Warfarin and MT-3995 Healthy | Phase 1 | 2015-06-01 |
| Completed | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects Healthy | Phase 1 | 2015-04-01 |
| Completed | Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease Crohn's Disease | Phase 2 | 2015-03-01 |
| Completed | Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients Systemic Lupus Erythematosus | Phase 1 | 2015-02-01 |
| Completed | Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin) Type 2 Diabetes Mellitus | Phase 3 | 2015-01-01 |
| Completed | Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin) Type 2 Diabetes Mellitus | Phase 3 | 2015-01-01 |
| Terminated | Safety Study of MT-4666 in Subjects With Alzheimer's Disease Alzheimer's Disease | Phase 3 | 2014-12-01 |
| Completed | Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 4 | 2014-12-01 |
| Completed | Comparative Oral Bioavailability Study of MT-1303 Relapsing-remitting Multiple Sclerosis | Phase 1 | 2014-11-01 |
| Completed | Mass Balance Study of MT-1303 Relapsing-remitting Multiple Sclerosis | Phase 1 | 2014-09-01 |
| Completed | Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 D Type 2 Diabetes Mellitus | Phase 4 | 2014-08-01 |
| Completed | Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2014-08-01 |
| Completed | Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabe Type 2 Diabetes Mellitus | Phase 4 | 2014-08-01 |
| Completed | Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy Diabetic Nephropathy | Phase 1 / Phase 2 | 2014-07-01 |
| Completed | Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease Crohn's Disease | Phase 1 | 2014-05-01 |
| Terminated | Dose-finding Study of MCI-196 Chronic Kidney Disease, Dialysis, Hyperphosphatemia | Phase 3 | 2014-04-01 |
| Completed | Exploratory Clinical Study of MT-2301 Haemophilus Influenza Type b | Phase 2 | 2014-04-01 |
| Completed | Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents Diphtheria, Tetanus, Pertussis | Phase 3 | 2014-04-01 |
| Completed | Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabet Type 2 Diabetes Mellitus | Phase 4 | 2014-01-01 |
| Completed | Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Ca Hyperphosphatemia, Chronic Kidney Disease | Phase 1 | 2013-10-01 |
| Completed | Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis Plaque Psoriasis | Phase 2 | 2013-09-01 |
| Completed | Extension Study of MT-1303 Relapsing-remitting Multiple Sclerosis | Phase 2 | 2013-08-01 |
| Terminated | Safety and Tolerability Study of MCI-196 Chronic Kidney Disease, Not on Dialysis, Hyperphosphatemia | Phase 3 | 2013-08-01 |
| Terminated | Long-term Extension Study of MCI-196 Chronic Kidney Disease, Dialysis, Hyperphosphatemia | Phase 3 | 2013-08-01 |
| Completed | Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy Diabetic Nephropathy | Phase 1 / Phase 2 | 2013-07-01 |
| Completed | A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis Perennial Allergic Rhinitis | Phase 3 | 2013-06-01 |
| Completed | The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis Perennial Allergic Rhinitis | Phase 3 | 2013-04-01 |
| Completed | A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis Dermatitis, Atopic | Phase 3 | 2013-03-01 |
| Completed | Clinical Pharmacology Study of MP-424 Chronic Hepatitis C | Phase 1 | 2013-02-01 |
| Completed | Dose-finding Study of MT-1303 Relapsing-remitting Multiple Sclerosis | Phase 2 | 2013-01-01 |
| Completed | Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve Chronic Hepatitis C (CHC) | Phase 3 | 2012-12-01 |
| Completed | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Diabetic Nephropathy | Phase 2 | 2012-12-01 |
| Completed | Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Rec Chronic Hepatitis C(CHC) | Phase 3 | 2012-12-01 |
| Completed | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Diabetic Nephropathy | Phase 2 | 2012-11-01 |
| Completed | Safety and Efficacy of MT-4666 Alzheimer's Disease | Phase 2 | 2012-11-01 |
| Completed | Long-Term Study of MP-214 in Patients With Schizophrenia Schizophrenia | Phase 2 / Phase 3 | 2012-09-01 |
| Completed | A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis Plaque Psoriasis, Psoriatic Arthritis, Pustular Psoriasis (Excluding a Localized) | Phase 3 | 2012-07-01 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bow Inflammatory Bowel Disease | Phase 1 | 2012-06-01 |
| Completed | A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia Schizophrenia | Phase 2 / Phase 3 | 2012-05-01 |
| Completed | A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia Schizophrenia | Phase 2 / Phase 3 | 2012-05-01 |
| Completed | Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin | Phase 3 | 2012-05-01 |
| Completed | Safety and Efficacy of MP-214 in Patients With Schizophrenia Schizophrenia | Phase 2 / Phase 3 | 2012-05-01 |
| Completed | A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia Schizophrenia | Phase 2 / Phase 3 | 2012-05-01 |
| Completed | Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Chronic Hepatitis C | Phase 3 | 2012-05-01 |
| Completed | Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease Pediatric Crohn's Disease | Phase 3 | 2012-03-01 |
| Completed | Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis Pediatric Ulcerative Colitis | Phase 3 | 2012-02-01 |
| Completed | A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderat Type 2 Diabetes Mellitus | Phase 1 | 2012-01-01 |
| Completed | Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions Behcet's Disease, Behcet Syndrome, Neuro-Behcet's Disease | Phase 3 | 2012-01-01 |
| Completed | Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis (ALS) | Phase 3 | 2011-12-01 |
| Completed | Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Inf Chronic Hepatitis C | Phase 3 | 2011-11-01 |
| Completed | A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis Perennial Allergic Rhinitis | Phase 3 | 2011-08-01 |
| Completed | Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2011-07-01 |
| Completed | Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 3 | 2011-05-01 |
| Completed | Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2011-02-01 |
| Completed | Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthrit Rheumatoid Arthritis | Phase 2 | 2010-06-01 |
| Completed | Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 3 | 2010-02-01 |
| Completed | Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2009-12-01 |
| Completed | An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 2 | 2009-11-01 |
| Completed | Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2009-09-01 |
| Completed | Monotherapy Study of MP-513 in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2009-09-01 |
| Completed | Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 2 | 2009-08-01 |
| Completed | Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabeti Type 2 Diabetes Mellitus | Phase 3 | 2009-08-01 |
| Completed | Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in H Dyslipidemia | Phase 1 | 2009-08-01 |
| Completed | Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II Heparin-induced Thrombocytopenia Type II | Phase 2 | 2009-04-01 |
| Completed | Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subj Chronic Kidney Disease | Phase 3 | 2009-03-01 |
| Completed | Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke Acute Ischemic Stroke (AIS) | Phase 2 | 2009-02-01 |
| Completed | Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieve Hepatitis C | Phase 3 | 2008-12-01 |
| Completed | Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia Chronic Kidney Disease, Dialysis, Hyperphosphatemia | Phase 3 | 2008-12-01 |
| Completed | Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD) Crohn's Disease | Phase 3 | 2008-12-01 |
| Completed | Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chr Hepatitis C | Phase 3 | 2008-11-01 |
| Completed | Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who R Chronic Hepatitis C | Phase 3 | 2008-11-01 |
| Completed | Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients Type 2 Diabetes Mellitus | Phase 1 / Phase 2 | 2008-06-01 |
| Completed | Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia Schizophrenia | Phase 2 | 2008-04-01 |
| Completed | A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C Hepatitis C | Phase 1 | 2008-04-01 |
| Completed | Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating D Dyslipidemia | Phase 1 | 2008-03-01 |
| Completed | Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes Type 2 Diabetes | Phase 2 | 2008-01-01 |
| Completed | Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C Hepatitis C | Phase 2 | 2008-01-01 |
| Completed | Safety and PK Study of MP-424 to Treat Chronic Hepatitis C Chronic Hepatitis C | Phase 1 | 2007-12-01 |
| Completed | A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia Chronic Kidney Disease, Dialysis, Hyperphosphatemia | Phase 3 | 2007-12-01 |
| Completed | A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia Chronic Kidney Disease, Dialysis, Hyperphosphatemia | Phase 3 | 2007-11-01 |
| Completed | A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on D Chronic Kidney Disease, Dialysis, Hyperphosphatemia | Phase 3 | 2007-09-01 |
| Completed | A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Chronic Kidney Disease | Phase 3 | 2007-07-01 |
| Completed | A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1) Chronic Kidney Disease | Phase 3 | 2007-07-01 |
| Completed | A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia Chronic Kidney Disease, Hyperphosphatemia | Phase 3 | 2007-06-01 |
| Terminated | A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Pati Chronic Kidney Disease, Dialysis, Hyperphosphatemia | Phase 3 | 2007-05-01 |
| Completed | Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (AL Amyotrophic Lateral Sclerosis (ALS) | Phase 3 | 2007-01-01 |
| Completed | Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Cla Amyotrophic Lateral Sclerosis (ALS) | Phase 3 | 2006-12-01 |
| Completed | Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ Stroke | Phase 4 | 2006-12-01 |
| Completed | Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis (ALS) | Phase 3 | 2006-05-01 |
| Completed | Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy Diabetic Polyneuropathy | Phase 2 | 2006-03-01 |
| Completed | Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes Type 2 Diabetes | Phase 2 | 2005-10-01 |
| Completed | Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2005-09-01 |
| Completed | Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Inter Coronary Artery Disease, Angina, Unstable | Phase 2 | 2005-08-01 |
| Completed | Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke Cerebral Infarction | Phase 4 | 2004-08-01 |
| Completed | Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-responsive Clinical Cerebral Infarction | Phase 3 | 2004-04-01 |
| Completed | MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocard Myocardial Infarction | Phase 2 | 2003-04-01 |
| Completed | Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C Chronic Hepatitis C | Phase 3 | 2002-07-01 |
| Completed | Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) Cerebral Infarction, Brain Ischemia | Phase 3 | 2002-04-01 |
| Completed | Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arteri Peripheral Vascular Disease | Phase 3 | 2001-08-01 |
| Terminated | Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arteri Peripheral Vascular Disease | Phase 3 | 2001-07-01 |
| Completed | Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral In Cerebral Infarction | Phase 3 | 2001-01-01 |
| Completed | A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303 Relapsing-remitting Multiple Sclerosis | Phase 1 | — |